bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India

Group Pharmaceuticals Ltd shares the same values with bonyf in being at the forefront of oral care innovations, committed to bringing the best oral care science to India. With three facilities across India, manufacturing multiple dosage forms, the facility at Tarapur, near Mumbai, is specially designed and equipped to manufacture moisture sensitive tablets requiring strict humidity control. The facilities are cGMP, PIC/S and WHO compliant. The internal SOPs are designed to be above statutory requirements, enabling them to achieve several ISO certifications. A month ago, Group Pharmaceuticals succeeded in the certification as to produce Medical Devices Class a and b, successful testing completed for the first bonyf selected formulation, both cornerstones for a successful alliance between the two oral care manufacturing experts.